日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect

CompEx哮喘的临床意义及其对疾病进程的影响:贝那利珠单抗的疗效

Bolton, Clare; Akuthota, Praveen; Lugogo, Njira; Barker, Peter; Bengtsson, Thomas; Peterson, Stefan; Siddiqui, Salman; Da Silva, Carla A

Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab

CompEx 在接受 benralizumab 治疗的重度、未控制哮喘的嗜酸性粒细胞增多症患者中的应用

Bolton, Clare; Harrison, Tim; Lugogo, Njira; Fuhlbrigge, Anne; Hirsch, Ian; Bengtsson, Thomas; Peterson, Stefan; Sidaway, Martin; Garcia Gil, Esther; Fagerås, Malin; Da Silva, Carla A

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

新型支气管扩张剂纳伐芬特罗:一项针对慢性阻塞性肺疾病的 2a 期多中心随机双盲安慰剂对照交叉试验

Singh, Dave; Beier, Jutta; Astbury, Carol; Belvisi, Maria G; Da Silva, Carla A; Jauhiainen, Alexandra; Jimenez, Eulalia; Lei, Alejhandra; Necander, Sofia; Smith, Jaclyn A; Wählby Hamrén, Ulrika; Xin, Wenjing; Psallidas, Ioannis

Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

针对年轻慢性阻塞性肺疾病患者和慢性阻塞性肺疾病前期患者的治疗试验:是时候向前迈进了。

Martinez, Fernando J; Agusti, Alvar; Celli, Bartolome R; Han, MeiLan K; Allinson, James P; Bhatt, Surya P; Calverley, Peter; Chotirmall, Sanjay H; Chowdhury, Badrul; Darken, Patrick; Da Silva, Carla A; Donaldson, Gavin; Dorinsky, Paul; Dransfield, Mark; Faner, Rosa; Halpin, David M; Jones, Paul; Krishnan, Jerry A; Locantore, Nicholas; Martinez, Fernando D; Mullerova, Hana; Price, David; Rabe, Klaus F; Reisner, Colin; Singh, Dave; Vestbo, Jørgen; Vogelmeier, Claus F; Wise, Robert A; Tal-Singer, Ruth; Wedzicha, Jadwiga A

Physical activity end-points in trials of chronic respiratory diseases: summary of evidence

慢性呼吸系统疾病试验中体力活动终点:证据总结

Rist, Cassie; Karlsson, Niklas; Necander, Sofia; Da Silva, Carla A

INEXAS: A Phase 2 Randomized Trial of On-demand Inhaled Interferon Beta-1a in Severe Asthmatics

INEXAS:一项针对重度哮喘患者按需吸入干扰素β-1a的II期随机试验

McCrae, Christopher; Olsson, Marita; Gustafson, Per; Malmgren, Anna; Aurell, Malin; Fagerås, Malin; Da Silva, Carla A; Cavallin, Anders; Paraskos, Jonathan; Karlsson, Karin; Wingren, Cecilia; Monk, Phillip; Marsden, Richard; Harrison, Tim

Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor size

早期呼吸系统临床试验设计的复杂性;评估主要终点和申办方规模的影响

Marco-Ariño, Nicolas; Jauhiainen, Alexandra; Betts, Joanne; Da Silva, Carla A

Impact of season and geography on CompEx Asthma: a composite end-point for exacerbations

季节和地理位置对哮喘急性发作综合终点的影响

Jauhiainen, Alexandra; Scheepers, Lieke E J M; Fuhlbrigge, Anne L; Harrison, Tim; Zangrilli, James; Garcia Gil, Esther; Gustafson, Per; Fagerås, Malin; Da Silva, Carla A

Chitin particles are multifaceted immune adjuvants

几丁质颗粒是多功能的免疫佐剂

Da Silva, Carla A; Pochard, Pierre; Lee, Chun Geun; Elias, Jack A

Chitin regulation of immune responses: an old molecule with new roles

几丁质调控免疫反应:一种古老分子的全新角色

Lee, Chun Geun; Da Silva, Carla A; Lee, Jae-Young; Hartl, Dominik; Elias, Jack A